Status:
COMPLETED
COVID-19 Messaging for Vaccination
Lead Sponsor:
Massachusetts Institute of Technology
Collaborating Sponsors:
Facebook, Inc.
Code3
Conditions:
Vaccination Refusal
COVID-19 Pandemic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will distribute videos of health professionals encouraging Covid-19 vaccination to a large sample of Facebook users, and will test the most effective ways to maximize diffusion of this vacc...
Detailed Description
The study will have three treatment arms and a control group. Each of the treatments will be randomized at the county level and will be initiated through a Facebook ad campaign. Experimental Sample: ...
Eligibility Criteria
Inclusion
- Facebook user
- Over 18 years old
- In a geographic area targeted by the study
Exclusion
- \-
Key Trial Info
Start Date :
December 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 27 2022
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT05182554
Start Date
December 22 2021
End Date
January 27 2022
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts Institute of Technology
Cambridge, Massachusetts, United States, 02139